Lidocaine Injection BP 2% w/v by Ancalima Lifesciences Limited is a high-quality anesthetic solution formulated to British Pharmacopoeia (BP) standards, widely used for local anesthesia during minor surgical and dental procedures. This sterile injectable solution contains Lidocaine at a concentration of 2% weight/volume, ensuring effective nerve block and pain relief. Supplied in a single 50ml vial pack, this product is ideal for healthcare professionals requiring precise dosage and reliability in anesthesia administration. Its formulation meets the stringent quality criteria outlined by BP, ensuring safety, efficacy, and consistency essential for clinical settings. Suitable for use in hospitals, clinics, and dental practices, this Lidocaine Injection provides fast-acting and efficient anesthetic effects for patient comfort and procedural success.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Lidocaine 2% w/v |
| Dosage Form | Injection (Solution) |
| Pharmacopoeia Standard | British Pharmacopoeia (BP) |
| Therapeutic Category | Anesthesia |
| Pack Type | Vial |
| Pack Size | Single Unit 50ml Vial |
| Sterility | Sterile solution suitable for injection |
| Intended Use | Local anesthesia during minor surgical and dental procedures |
| Storage Condition | Store as per BP guidelines, protected from light and excessive heat |
| Attributes | Description |
|---|---|
| Lidocaine Concentration | 2% w/v |
| Volume per Vial | 50 ml |
| Pharmacopoeia Compliance | British Pharmacopoeia (BP) certified |
| Formulation | Clear, sterile injectable solution |
| Intended Administration Route | Intravenous, Subcutaneous, or Local infiltration |
| Packaging | Single vial in protective packaging |
| Shelf Life | As per manufacturer specification |
| MOQ | 1 vial |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, this Lidocaine Injection at 2% w/v concentration complies with British Pharmacopoeia standards and is designed for effective local anesthesia in both dental and minor surgical procedures.
Each vial contains 50 ml of sterile Lidocaine 2% w/v solution, suitable for multiple administrations as required.
Yes, it is manufactured in compliance with the British Pharmacopoeia (BP) standards ensuring quality and safety.
The minimum order quantity (MOQ) for Lidocaine Injection BP 2% w/v is 1 vial.
It should be stored as per BP guidelines, typically in a cool place, protected from light and excessive heat to maintain efficacy.
Country Of Origin: India
Lidocaine Injection BP is a biocompatible injectable local anesthetic delivering 2% w/v solution, designed for rapid onset analgesia and procedural anesthesia in clinical environments.
The 2% w/v specification ensures standardized anesthetic effect, suitable for surgical, diagnostic, and institutional applications.
Lidocaine Injection BP contains pharmaceutically pure lidocaine hydrochloride dissolved in sterile isotonic medium with stabilizers to maintain solubility and chemical integrity. This ensures consistent local anesthetic efficacy per administered volume.
The low-viscosity injectable allows smooth administration with rapid tissue penetration and predictable pharmacokinetics. Controlled pH and osmolarity reduce the risk of injection site irritation. The formulation remains stable under standard storage conditions for bulk clinical use.
Widely applied in surgical procedures, dental practices, and institutional clinical settings, this injection is suitable for bulk sourcing, OEM supply, and export-ready pharmaceutical operations. Its standardized 2% w/v concentration ensures repeatable anesthetic performance in professional B2B markets.
